# Phase 4A Priority 3 SOTA Clinical Context Injection Report

## Decision

`IMPLEMENTED_ACCEPTED`

Effectiveness remains `EFFECTIVENESS_PENDING` until the Phase 4B semantic delta rerun confirms COG-002 improvement.

## Scope

This patch addresses COG-002 by adding a workflow-level SOTA clinical context injection node before benchmark derivation.

It does not change:

- G30/G33/G38 or other gate criteria
- 1+6 agent membership or role allocation
- Phase 0.6 device identity arbitration
- `BASELINE_V2.4` structural pipeline intent

## Workflow Position

The evidence branch now runs:

```text
evidence_appraisal
→ sota_clinical_context
→ endpoint_extraction / SOTA benchmark derivation
→ evidence_review_gates
```

The node injects domain-specific clinical context before endpoint extraction creates the SOTA derivation and quantitative benchmark tables.

## Added Artifacts

- `sota_clinical_context_table.xlsx`
- `sota_benchmark_contextual_rationale.xlsx`
- `sota_context_injection_trace.xlsx`

These are also included in `authoring_workbook.json` and Annex O.

## Rationale Content

Each benchmark is enriched with:

- medical field and clinical pathway
- target condition or use context
- unmet need
- alternative or comparator context
- hazard context
- endpoint selection reason
- benchmark value interpretation
- overclaim guard
- relation to section 4.7

## Expected Effect

SOTA benchmark rationale should move from generic placeholder language such as "rates to be extracted" toward domain-aware clinical reasoning that explains why the endpoint matters, why the benchmark is clinically meaningful, and how limitations control conclusion strength.

## Verification

Added regression tests for:

- clinical context injection before benchmark derivation
- domain-aware rationale appearing in SOTA derivation rows
- workbook and export inclusion of the new artifacts

